Background. Resistance to antimicrobials has become a global issue. To combat this, registered nurses (RNs) need to be active participants with prescribers in an interdisciplinary approach to antimicrobial stewardship (AS). The prescriber role in AS has been well developed; however, more is needed to understand how RNs can contribute to AS efforts. The purpose of this study was to describe nurses comfort level with questioning providers about antimicrobials.
Methods. A survey was sent to point of care RNs in a healthcare system (approx. 4000). A total of 600 useable responses were received (Response rate = 15%). The survey included 4-items about antimicrobial delivery. (1) What percent of the time do you know why the patient is receiving an antimicrobial? (2) Would you feel comfortable raising concerns about antimicrobials to the treatment team? (3) In the last 30 days have you questioned the antimicrobial choice, dose, route or duration? (4) Have you ever given an antimicrobial you thought was inappropriate? Data were analyzed using descriptive statistics. Differences by demographics (age, gender, ethnicity, education level and location) were assessed using χ 2 statistics.
Results. Nurses reported that 84% of the time they knew "why" an antimicrobial was given. There was no difference by demographics. Over 80% of nurses also reported they felt comfortable raising concerns about antimicrobials. Nurses working in smaller hospitals reported being more comfortable raising concerns than nurses working in larger hospitals (P = 0.023). In the past 30 days, 19% of RNs questioned choice, 13% dose, 16% route, and 27% duration of antimicrobials. Nurses with Baccalaureate degree or higher were more likely to question antimicrobial dose (P = .023). However, 27% of RNs reported they had given an antimicrobial they thought was inappropriate. More RNs working in rural hospitals reported giving antimicrobials they thought were inappropriate compared with those working in larger hospitals (P = .013).
Conclusion. Providers as well as RNs need to collaborate to improve AS. Nurses in this study were not always comfortable raising concerns and administered antimicrobials they viewed as inappropriate. Providers may want to take steps to encourage collaboration with RNs about AS.
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Electronic Capture and Feedback of Standardized Antibiotic Clinical Indications Data Among Community Hospitals

Background.
Antibiotic clinical indications allow stewardship programs to assess therapy appropriateness; however, many hospitals that require antibiotic indications upon order entry lack standardized mapping of indications leading to variability in entered values. Electronic capture and feedback of standardized antibiotic clinical indications data may allow hospitals to more effectively compare indication-specific prescribing trends among facilities.
Methods.
We collected antibiotic indications from electronic medication orders for 6 DASON hospitals. These indications were mapped to a list of 15 standardized indication categories created by consensus of the DASON stewardship team. To demonstrate the feasibility and utility of standardized clinical indications mapping, we evaluated agents given for the indication C. difficile infection (CDI) in 2018. Differences between the hospitals were compared with highlight the added benefit of standardized indication data in evaluating antibiotic use and adoption of local guidelines.
Results. For 249,916 antibiotic days of therapy (DOT) with an indication available, a total of 125 unique indications were reported. Of note, 3 facilities allowed more than one indication to be entered at prescriber discretion. The distribution of antibiotic DOT mapped to the standardized indication list can be seen in Figure  1 . The most common indication was the other category (19.5%). These were primarily other, no additional information (47%) or empiric therapy for an unknown source of infection (17%). Additional indications in the other category included chronic obstructive pulmonary disease exacerbations and sexually transmitted infections (< 5% each). Figure 2 depicts the agents used for CDI indication between facilities. Despite universal adoption of local guidelines where oral vancomycin is the drug of choice for treating CDI, there was variability seen in vancomycin CDI DOT (range: 60 -80% of CDI DOT).
Conclusion. Stewardship programs can implement standardized antimicrobial indications to facilitate electronic capture, feedback, and comparison and efficiently identify stewardship targets. Additionally, hospitals may use these data to explore the appropriateness of antibiotic use.
